https://phrma.org/blogs/rss PhRMA Blog RSS Feed for Sitecore Send Repeatable Campaigns en-us 13958 https://phrma.org/blog/it-s-time-to-modernize-340b-the-case-for-a-rebate-model Elise Shutzer, August 19, 2026 The Health Resources and Services Administration’s (HRSA) announcement of the revised 340B Rebate Model Pilot Program is an important step to bring greater transparency, accountability and integrity to a program that has grown in size and complexity. Wed, 19 Aug 2026 04:00:00 GMT 13955 https://phrma.org/blog/policymakers-should-improve-patient-access-and-reject-price-controls Elizabeth Carpenter, August 18, 2026 As policymakers consider what's next for prescription drug policy, they should focus on the barriers keeping patients from their medicines, not expand government price controls that could further undermine access. Tue, 18 Aug 2026 15:21:05 GMT 13953 https://phrma.org/blog/cms-proposal-could-discourage-patient-centered-innovation Jocelyn Ulrich, August 18, 2026 In comments submitted yesterday on CMS's IPAY 2029 proposed rule, PhRMA urges the agency to reconsider a proposal that could discourage investment in new treatments designed to be more convenient and accessible for patients. Tue, 18 Aug 2026 04:00:00 GMT 13952 https://phrma.org/blog/icymi-biopharmaceutical-companies-in-america-hit-new-investment-milestone Jocelyn Ulrich, August 14, 2026 PhRMA member companies have invested more than $900 billion in the search for new treatments and cures over the last decade, including more than $110 billion in 2025 alone. Fri, 14 Aug 2026 16:06:45 GMT 13946 https://phrma.org/blog/insurers-blame-glp-1s-for-rising-costs-the-data-tell-a-different-story Eliza Maciag, August 14, 2026 Insurers are pointing a finger at innovative GLP-1 treatments to justify rising premiums. But new federal data show medicines are not the primary driver of rising health care costs.   Fri, 14 Aug 2026 04:00:00 GMT 13928 https://phrma.org/blog/phrma-highlights-need-for-germany-to-pay-its-fair-share Brian Picone, August 11, 2026 The big picture: Across the world, high-income countries use price controls to avoid paying their fair share for innovative medicines, placing the burden on the United States to finance these innovations for the world.   Tue, 11 Aug 2026 14:35:15 GMT 13909 https://phrma.org/blog/the-ftc-s-pbm-enforcement-actions-gave-us-a-glimpse-behind-the-curtain-it-s-time-to-let-the-light-in Eliza Maciag, August 7, 2026 The Federal Trade Commission has pulled back the curtain on the historically opaque pharmacy benefit manager industry. The FTC’s settlements with CVS Caremark and Express Scripts, with an OptumRx agreement expected, represent a major federal intervention into predatory PBM practices.  Fri, 07 Aug 2026 04:00:00 GMT 13902 https://phrma.org/blog/nearly-1-in-4-patients-initially-denied-access-to-ira-medicines Brianna Allen, August 6, 2026 The IRA promised to improve patient access, but growing evidence suggests it is falling short.  Thu, 06 Aug 2026 12:29:57 GMT 13887 https://phrma.org/blog/why-smart-vaccine-policy-matters Mike Ybarra, August 3, 2026 Today, PhRMA released a new issue brief on the health and economic impact of vaccines and the importance of maintaining access to vaccination. Mon, 03 Aug 2026 04:00:00 GMT 13868 https://phrma.org/blog/voters-continue-to-voice-their-concerns-on-government-price-controls Tom Wilbur, July 24, 2026 Across the country and building on a cohort of voices from earlier this year, Voters for Cures advocates are continuing to speak out against government price controls like Most Favored Nation (MFN).   Fri, 24 Jul 2026 14:05:36 GMT 13854 https://phrma.org/blog/icymi-fox-business-hosts-call-340b-a-rotten-system-and-cash-cow-for-hospitals Eliza Maciag, July 23, 2026 Scrutiny of the 340B program continues to gain traction in Washington and in the media. Across multiple Fox Business segments—including Varney & Co., Mornings with Maria and The Big Money Show—hosts and correspondents described the program as a “rotten system” and a “cash cow” for hospitals while highlighting concerns that 340B lacks accountability and may benefit hospitals more than patients. Thu, 23 Jul 2026 04:00:00 GMT 13852 https://phrma.org/blog/medicare-part-d-at-20-building-on-a-strong-foundation Matthew Norawong, July 23, 2026 This year marks the 20th anniversary of Medicare Part D, a landmark benefit that transformed access to prescription medicines for millions of seniors and people with disabilities. As Medicare reaches its 61st year, Part D remains one of the program's most important achievements. Thu, 23 Jul 2026 04:00:00 GMT 13860 https://phrma.org/blog/message-to-usaging-providers-are-raising-concerns-about-coverage-barriers Sharon Lamberton, MS, RN , July 22, 2026 As a nurse, I know access to the right medicine at the right time can make a meaningful difference for patients managing chronic and complex conditions. This week, I joined USAging at their Answers on Aging conference to continue a conversation that providers and patients across the country are raising their voices on.  Wed, 22 Jul 2026 19:09:35 GMT 13851 https://phrma.org/blog/hpv-vaccination-helps-prevent-cervical-cancer-deaths Carolyn Ha, July 21, 2026 A new study published in The Lancet offers some of the strongest real-world evidence to date that vaccination against human papillomavirus (HPV) is saving lives. Tue, 21 Jul 2026 16:35:06 GMT